Serum Levels of Interleukins 8 and 10, Interferon γ, Granulocyte-macrophage Colony Stimulating Factor and Soluble CD23 in Patients with Primary Sclerosing Cholangitis

References

• Snook J. A., Chapman R. W., Fleming K., Jewell D. P. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Imm. 1989; 76: 30–33
   PubMedGoogle Scholar
• Das K. M., Vecchi M., Sakamaki S. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by monoclonal antibody. Gastroenterology 1990; 98: 464–69
   PubMed Web of Science ®Google Scholar
• Siebold F., Slametschka D., Gregor M., Weber P. Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994; 107: 532–36
   Google Scholar
• Seibold F., Weber R., Berg P. A., Wiedmann K. H. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992; 33: 657–62
   PubMed Web of Science ®Google Scholar
• Duerr R. H., Targan S. R., Landers C. J., Larusso N. F., Lindsay K. L., Wiesner R. H., Shanahan F. Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100: 1385–1391
   PubMed Web of Science ®Google Scholar
• Chapman R. W., Varghese Z., Gaul R., Patrl G., Koki-Non N., Sherlock S. Association of primary sclerosing cholangitis with HLA B8. Gut 1983; 24: 38–41
   PubMed Web of Science ®Google Scholar
• Doanldson P. T., Farrant J. M., Wilkinson M. L., Hayl-Lar K., Portmann B. C., Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 1991; 13: 129–133
   Google Scholar
• Weisner R. H., LaRusso N. F., Ludwig J., Dickson E. R. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 1985; 88: 108–114
   Google Scholar
• Senaldi G., Donaldson P. T., Magrin S., Farrant J. M., Alexander G. J., Vergani D. Activation of the complement system in primary sclerosing cholangitis. Gastroenterology 1989; 97: 1430–1434
   PubMed Web of Science ®Google Scholar
• Minuk G. Y., Angus M., Brickman C. M., Lawley T. J., Frank M. M., Hoofnagle J. H. Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology 1985; 88: 166–70
   PubMedGoogle Scholar
• Bansal A. S., Roberts T., Hay E. M., Kay R., Pumphrey R. S. H., Wilson P. B. Soluble CD23 levels are elevated in the serum of patients with primary Sjögrens syndrome and SLE. Clin Exp Immunol 1992; 89: 452–55
   PubMedGoogle Scholar
• Delespesse G., Suter U., Mossalayi D., Bettler B., Sarfa-Tio M., Sarfati M, Hofstetter H., Kilcherre E., Debre P., Dalloul A. A. Expression, structure and function of the CD23 antigen. Adv Immunol 1991; 49: 149–91
   PubMed Web of Science ®Google Scholar
• Gordon J. CD23 and B cell activation. Clin Exp Allergy 1992; 22: 199–204
   PubMed Web of Science ®Google Scholar
• Bansal A. S., Cochrane S., Haeney M. R., Bhavnani M., Pumphrey R. S. H., Wilson P. B. Serum soluble CD23 in conditions with hypogammaglobulinaemia and varying B cell numbers. Clin Exp Immunol 1994; 97: 239–41
   PubMedGoogle Scholar
• Mossalayi M. D., Dalloul A. H., Fourcade C, Arcock M., Merle-Beral H., Hoffstetter H., Debre P. The role of CD23 on early human haematopoietic precursors. Monogr Allergy 1991; 29: 178–85
   Google Scholar
• Bansal A. S., MacGregor A. J., Pumphrey R. S. H., Oilier W. E. R., Silman A. J., Wilson P. B. Increased levels of sCD23 in rheumatoid arthritis are related to disease status. Clin Exp Rheumatol 1994; 12: 281–85
   PubMedGoogle Scholar
• Bansal A. S., Oilier W., Marsh M. N., Pumphrey R. S. H., Wilson P. B. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology 1993; 79: 285–89
   PubMedGoogle Scholar
• Niessner M., Volk B. A. Altered Thl/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101: 428–35
   PubMed Web of Science ®Google Scholar
• Sasaki T., Hiwatashi N., Yamazaki H., Noguchi M., Toypota T. The role of interferon y in the pathogenesis of Crohn's disease. Gastroenterologia Japonica 1992; 27: 29–35
   PubMedGoogle Scholar
• Al-Janadi M., Al-Wabel A., Raziuddin S. Soluble CD23 and Interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus. Clin Imm andImmunopathy 1994; 71: 33–37
   PubMedGoogle Scholar
• Cush J. J., Splawski J. B., Thomas R., McFarlin J. E., Schulze-Koops H., Davis L. S., Fujita K., Lip-Sky P. E. Elevated interleukin-10 in patients with rheumatoid arthritis. Arthritis Rheumatism 1995; 38: 96–104
   PubMed Web of Science ®Google Scholar
• Llorente L., Richaud-Patin Y., Fior R., Alcocer-Varela J., Wijdenes O., Fourrier B. M., Galanaud P., Emilie D. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogrens syndrome and systemic lupus erythematosus. Arthritis Rheumatism 1994; 37: 1647–1655
   PubMed Web of Science ®Google Scholar
• Kucharzik T., Stoll R., Lügering N., Domschke W. Circulating antiinflammatory cytokine IL10 in patients with inflammatory bowel disease. Clin Exp Imm. 1995; 101: 452–456
   Google Scholar
• Niessner M., Volk B. A. Altered Thl/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Imm. 1995; 101: 428–435
   PubMed Web of Science ®Google Scholar
• Howard M., O'Garra A. Biological properties of interleukin 10. Imm Today 1992; 13: 198–200
   PubMedGoogle Scholar
• Schreiber S., Heinig T., Heinz-Gunther T., Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 1434–44
   PubMed Web of Science ®Google Scholar
• Saviege J. A., Davies D. J., Gatenby P. A. Anti-neutrophil cytoplasmic antibodies (ANCA): Their detection and significance: Report from workshops. Pathology 1994; 26: 186–193
   Google Scholar